Relationship of Glioblastoma Multiforme to the Lateral Ventricles Predicts Survival Following Tumor Resection

Overview

Journal J Neurooncol

Publisher Springer

Date 2008 May 7

PMID 18458819

Citations 84

Authors

Kaisorn L Chaichana

Matthew J McGirt

James Frazier

Frank Attenello

Hugo Guerrero-Cazares

Alfredo Quinones-Hinojosa

Affiliations

Soon will be listed here.

Abstract

Objective: There has been an increased focus on the region adjacent to the lateral ventricles (LV) as a potential source of malignant tumors and/or more aggressive disease. We set out to determine if glioblastoma multiforme (GBM) bordering the LV was associated with decreased survival as compared to non-LV GBM.

Methods: We reviewed the clinical records of 69 consecutive patients undergoing craniotomy for GBM at a single academic institution. Twenty-six patients were identified with contrast-enhancing lesions (CEL) bordering the LV (LV CEL). These 26 patients were matched with 26 patients with CEL not bordering the LV (non-LV CEL). These cohorts were matched for factors consistently shown to be associated with survival, which were age, tumor size, Karnofsky performance score, extent of resection, Gliadel implantation, and Temodar chemotherapy. Overall survival was compared between the cohorts via Log-rank analysis.

Results: Despite similarities in pre-operative clinical status, tumor size, peri-operative outcome, and treatment regimens, the median survival for patients with LV CEL was significantly decreased as compared to patients with non-LV CEL (8 months vs. 11 months), P = 0.02. Additionally, survival analysis in patients stratified by primary and secondary resection also demonstrated a strong trend towards decreased survival after resection of LV CEL. After primary and secondary resection, patients with LV CEL versus non-LV CEL had a median survival of 11 months vs. 14 months (P = 0.10) and 7 months vs. 10 months (P = 0.11), respectively.

Conclusion: While the causal factors underlying this observation are not provided with this observational study, GBM bordering the LV may carry a prognostic significance.

Citing Articles

Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.

Fares J, Wan Y, Gurung B, Nazar T, Mair R, Joannides A J Neurooncol. 2025; .

PMID: 40045105 DOI: 10.1007/s11060-025-04991-5.

Evaluating prognosis and survival in patients with glioblastoma in contact with subventricular zone: Tumor location and its correlation with prognosis.

Fattahi E, Kankam S, Khoshnevisan A, Hashemi A Med J Armed Forces India. 2024; 80(Suppl 1):S21-S28.

PMID: 39734827 PMC: 11670616. DOI: 10.1016/j.mjafi.2022.06.012.

[Glioblastoma and its interaction with neurogenesis].

Rodriguez-Mendoza B, Figueroa-Gonzalez A, Cano-Herrera G, Gutierrez-Rosas L, Romero-Torres C, Victoria-Garcia L Rev Neurol. 2024; 79(10):279-287.

PMID: 39540380 PMC: 11605900. DOI: 10.33588/rn.7910.2024226.

Effectiveness and safety of Tachosil® as a ventricular sealant: an observational cohort study.

Teixidor-Rodriguez P, Brugada-Bellsola F, Menendez-Giron S, Tardaguila-Serrano M, Gonzalez-Crespo A, Nunez-Marin F Acta Neurochir (Wien). 2024; 166(1):384.

PMID: 39331127 DOI: 10.1007/s00701-024-06276-8.

Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone.

Norton E, Whaley L, Jones V, Brooks M, Russo M, Morderer D Sci Adv. 2024; 10(32):eadn1607.

PMID: 39110807 PMC: 11305394. DOI: 10.1126/sciadv.adn1607.

References

Lim D, Cha S, Mayo M, Chen M, Keles E, Vandenberg S . Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol. 2007; 9(4):424-9. PMC: 1994099. DOI: 10.1215/15228517-2007-023. View

Calabrese C, Poppleton H, Kocak M, Hogg T, Fuller C, Hamner B . A perivascular niche for brain tumor stem cells. Cancer Cell. 2007; 11(1):69-82. DOI: 10.1016/j.ccr.2006.11.020. View

Ljubimova J, Fujita M, Khazenzon N, Ljubimov A, Black K . Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. Front Biosci. 2005; 11:81-8. PMC: 3506377. DOI: 10.2741/1781. View

Tait M, Petrik V, Loosemore A, Bell B, Papadopoulos M . Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br J Neurosurg. 2007; 21(5):496-500. DOI: 10.1080/02688690701449251. View

Quinones-Hinojosa A, Chaichana K . The human subventricular zone: a source of new cells and a potential source of brain tumors. Exp Neurol. 2007; 205(2):313-24. DOI: 10.1016/j.expneurol.2007.03.016. View

Alvarez-Buylla A, Lim D . For the long run: maintaining germinal niches in the adult brain. Neuron. 2004; 41(5):683-6. DOI: 10.1016/s0896-6273(04)00111-4. View

Carson K, Grossman S, Fisher J, Shaw E . Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol. 2007; 25(18):2601-6. PMC: 4118746. DOI: 10.1200/JCO.2006.08.1661. View

Sanai N, Tramontin A, Quinones-Hinojosa A, Barbaro N, Gupta N, Kunwar S . Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature. 2004; 427(6976):740-4. DOI: 10.1038/nature02301. View

Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View

10.

Parsa A, Wachhorst S, Lamborn K, Prados M, McDermott M, Berger M . Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg. 2005; 102(4):622-8. DOI: 10.3171/jns.2005.102.4.0622. View

11.

Laws E, Parney I, Huang W, Anderson F, Morris A, Asher A . Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003; 99(3):467-73. DOI: 10.3171/jns.2003.99.3.0467. View

12.

Lamborn K, Chang S, Prados M . Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004; 6(3):227-35. PMC: 1871999. DOI: 10.1215/S1152851703000620. View

13.

DeAngelis L . Brain tumors. N Engl J Med. 2001; 344(2):114-23. DOI: 10.1056/NEJM200101113440207. View

14.

Jalali R, Basu A, Gupta T, Munshi A, Menon H, Sarin R . Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience. Br J Neurosurg. 2007; 21(6):583-7. DOI: 10.1080/02688690701604574. View

15.

Chang S, Parney I, McDermott M, Barker 2nd F, Schmidt M, Huang W . Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003; 98(6):1175-81. DOI: 10.3171/jns.2003.98.6.1175. View

16.

Savarese T, Jang T, Low H, Salmonsen R, Litofsky N, Matuasevic Z . Isolation of immortalized, INK4a/ARF-deficient cells from the subventricular zone after in utero N-ethyl-N-nitrosourea exposure. J Neurosurg. 2005; 102(1):98-108. DOI: 10.3171/jns.2005.102.1.0098. View

17.

Zhu Y, Guignard F, Zhao D, Liu L, Burns D, Mason R . Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell. 2005; 8(2):119-30. PMC: 3024718. DOI: 10.1016/j.ccr.2005.07.004. View

18.

Sanai N, Alvarez-Buylla A, Berger M . Neural stem cells and the origin of gliomas. N Engl J Med. 2005; 353(8):811-22. DOI: 10.1056/NEJMra043666. View

19.

Brem H, Piantadosi S, Burger P, Walker M, SELKER R, Vick N . Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet. 1995; 345(8956):1008-12. DOI: 10.1016/s0140-6736(95)90755-6. View

20.

Holland E, Celestino J, Dai C, Schaefer L, Sawaya R, Fuller G . Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet. 2000; 25(1):55-7. DOI: 10.1038/75596. View